Noise in a Metabolic Pathway Leads to Persister Formation in Mycobacterium tuberculosis
Authors:
Open Access
- 26 October 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (5) , e0294822
Abstract
M. tuberculosis infection requires the administration of multiple antibiotics for a prolonged period of time. Treatment difficulty is generally attributed to M. tuberculosis entrance into a nonreplicative, antibiotic-tolerant state. M. tuberculosis enters this nonreplicative state in response to immune stress.Keywords
All Related Versions
Funding Information
- HHS | National Institutes of Health (R01 AI141966)
This publication has 59 references indexed in Scilit:
- Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and DiseaseFrontiers in Immunology, 2013
- Characterization and Transcriptome Analysis of Mycobacterium tuberculosis PersistersmBio, 2011
- Metabolic Regulation of Mycobacterial Growth and Antibiotic SensitivityPLOS Biology, 2011
- Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic FibrosisJournal of Bacteriology, 2010
- The Mycobacterium tuberculosis DosR Regulon Assists in Metabolic Homeostasis and Enables Rapid Recovery from Nonrespiring DormancyJournal of Bacteriology, 2010
- Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coliPLOS Biology, 2010
- Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viabilityMicrobiology, 2009
- Mycobacterium tuberculosis and the Macrophage: Maintaining a BalanceCell Host & Microbe, 2008
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005
- Bacterial Persistence as a Phenotypic SwitchScience, 2004